SQ109

#	Item
1	For immediate release March 21, 2017 Infectex Announces Positive Phase 2b-3 Clinical Trial Results of SQ109 for the Treatment of Multidrug-Resistant Pulmonary Tuberculosis Moscow, Russia and Rockville, MD, USA -- Infecte Add to Reading List Source URL: www.sequella.com Language: English - Date: 2017-03-23 09:36:00
2	Microsoft Word - SQ109 TB Product Summary FINAL.docx Add to Reading List Source URL: www.sequella.com Language: English - Date: 2013-08-02 15:11:58 Microbiology R207910 SQ109 Pyrazinamide Isoniazid Ethambutol Tuberculosis treatment Multi-drug-resistant tuberculosis Tuberculosis Medicine Pharmacology